Ranbaxy recalls three drugs from UK market
This is the second episode of recall that Ranbaxy is having to undertake this year and the fifth within last two years from the UK market. Only three months back, the firm had to recall skin infection drug, Isotretinoin, from the UK.
The recall itself would have an insignificant financial impact on the drugmaker, but several recalls in quick succession could be a source of huge embarrassment for the company as these events are closely tracked by drug regulators across countries.
The batches of three drugs that Ranbaxy has been asked to remove from the market were scheduled to expire between May 2013 and January 2014. The concerned set of drugs were manufactured between October 2010 to February 2011
A company spokesperson confirmed the recall to FE. “Ranbaxy UK has recalled one batch each
Be the first to comment.